Foreign investors continue to pull back money from the Indian equity market, withdrawing Rs 24,753 crore (about $2.8 billion) in the first week of March amid escalating global trade tensions and lacklustre corporate earnings. This came following an outflow of
Global trends, macroeconomic announcements and US tariff developments are expected to drive stock markets in a holiday-shortened week, analysts said. Market participants will also closely track foreign investor activity, geopolitical tensions, and their impact on the US dollar and crude
Financial services firm Tata Capital is likely to file preliminary papers with markets regulator Sebi to raise $2 billion (over Rs 17,000 crore) through an initial public offering (IPO) only after getting final approval from the NCLT for Tata Motors
Electric two-wheeler maker Ather Energy Ltd has taken a significant step toward its much-anticipated initial public offering (IPO) by converting its outstanding compulsory convertible preference shares (CCPS) into equity. The move is part of the company’s preparation for its IPO,
Mumbai, Global trends, macroeconomic announcements and US tariff developments are expected to drive stock markets in a holiday-shortened week, analysts said. Market participants will also closely track foreign investor activity, geopolitical tensions, and their impact on the US dollar and
After heightened activity in 2024, there has been a slowdown in new listings, with no main-bourse IPOs hitting the market in the past three weeks due to a correction in the secondary market. This slowdown in IPO activity is reflected
Finance Minister Nirmala Sitharaman on Saturday said the GST rates will come down further and the work on rationalising tax rates and slabs has “almost reached a finale”. Photograph: ANI Photo She said that the revenue neutral rate (RNR) has
Finance Minister Nirmala Sitharaman on Saturday said India is looking for a “good” trade agreement with the US to promote economic growth and ensure smooth supply chains. Photograph: ANI Photo She also said that amid a growing global tariff war,
Indian pharmaceutical companies may have units abroad as part of “distributed manufacturing” across various locations, according to industry veterans. This may come about over the next five to 10 years. There will be more interdependence between research and development (R&D)
Despite heavy foreign outflows of over $20 billion since September 2024, top global investors remain optimistic about India’s long-term growth prospects, even as they acknowledge near-term concerns over valuations and cyclical adjustments. Speaking at Moneycontrol’s Global Wealth Summit, Vishal Mahadevia,
